Moderna Inc (MRNA)
125.65
+14.19
(+12.73%)
USD |
NASDAQ |
May 02, 16:00
123.00
-2.65
(-2.11%)
After-Hours: 20:00
Moderna Cash from Operations (TTM): -3.118B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.118B |
September 30, 2023 | -2.078B |
June 30, 2023 | -226.00M |
March 31, 2023 | 993.00M |
December 31, 2022 | 4.981B |
September 30, 2022 | 6.629B |
June 30, 2022 | 9.653B |
March 31, 2022 | 13.41B |
December 31, 2021 | 13.62B |
September 30, 2021 | 11.57B |
June 30, 2021 | 9.191B |
Date | Value |
---|---|
March 31, 2021 | 5.104B |
December 31, 2020 | 2.027B |
September 30, 2020 | 663.95M |
June 30, 2020 | -336.15M |
March 31, 2020 | -420.73M |
December 31, 2019 | -459.00M |
September 30, 2019 | -450.97M |
June 30, 2019 | -424.08M |
March 31, 2019 | -363.75M |
December 31, 2018 | -330.86M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.118B
Minimum
Dec 2023
13.62B
Maximum
Dec 2021
3.702B
Average
993.00M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 3.676B |
Merck & Co Inc | 13.01B |
Pfizer Inc | 8.70B |
Johnson & Johnson | 23.19B |
Novavax Inc | -713.97M |